Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The clinical drug development program was halted in 2007 after the pivotal Phase IIb trial did not show statistically significant weight loss in the primary endpoint
PMID 27806244
Be sure to verify the correct coding and billing procedures for each insurance plan to avoid delays or denials
Three to four daily doses achieve eugonadal levels of circulating testosterone comparable to normal pulsatile regulated release of testosterone
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
